| |
Date
|
Headline
|
Company
|
|
|
August 25, 2010
|
Therapeutic focus - Will hopes evaporate as gene therapy pipeline flows?
|
Vical
|
|
|
August 19, 2010
|
Therapeutic focus - What are plan B options if A-beta Alzheimer's hypothesis is void?
|
Baxter International
|
|
|
August 16, 2010
|
Therapeutic focus - Vectibix failure leaves few new options for head and neck cancer
|
Merck KGaA
|
|
|
August 11, 2010
|
Therapeutic focus - Anti-infectives market shrinking as new superbug fears emerge
|
GlaxoSmithKline
|
|
|
August 02, 2010
|
Therapeutic focus – ALS field entering pivotal stage
|
Sanofi-Aventis
|
|
|
July 26, 2010
|
Therapeutic focus - Anti-thrombotics face a period of change
|
Sanofi-Aventis
|
|
|
July 20, 2010
|
Vantage Point - Cochrane report polarises the AAT world
|
Talecris Biotherapeutics
|
|
|
July 19, 2010
|
Therapeutic focus – Novel HIV approaches continue to suffer lack of interest
|
Gilead Sciences
|
|
|
July 15, 2010
|
Therapeutic focus - Avandia's decline and the type 2 diabetes market
|
GlaxoSmithKline
|
|
|
July 05, 2010
|
Therapeutic focus - Sanofi snaps up rare upartnered JAK-2 inhibitor
|
Sanofi-Aventis
|
|
|
June 01, 2010
|
Therapeutic focus - Innovation lags in stroke treatment
|
Stem Cell Therapeutics
|
|
|
May 27, 2010
|
Therapeutic focus - Novartis announces ovarian failure as Asco approaches
|
Novartis
|
|
|
May 20, 2010
|
Therapeutic focus - Friedreich's ataxia a goal with few shots
|
Santhera Pharmaceuticals
|
|
|
May 12, 2010
|
Data from late-stage cancer vaccine pipeline on distant horizon
|
GlaxoSmithKline
|
|
|
April 26, 2010
|
Therapeutic focus - Sutent liver cancer failure leaves thin late-stage pipeline
|
Pfizer
|
|
|
April 22, 2010
|
Therapeutic focus - A2A antagonists lining up to enter final stage Parkinson's trials
|
Kyowa Hakko Kirin
|
|
|
April 20, 2010
|
Array recovery gathers momentum with Novartis deal, spotlight on MEK inhibitors
|
Array BioPharma
|
|
|
March 31, 2010
|
Therapeutic focus - Late stage set backs sharpen focus on earlier lung cancer candidates
|
AstraZeneca
|
|
|
March 15, 2010
|
Notice of Extraordinary General Meeting |
Orexo
|
|
|
February 23, 2010
|
Therapeutic focus - Avastin stomach cancer failure leaves only pipeline follow-ons
|
Roche
|
|
|
February 18, 2010
|
Event – Menveo PDUFA important for Novartis' assault on meningitis vaccines
|
Novartis
|
|
|
February 16, 2010
|
Therapeutic focus - Hepatitis C waits for better treatments
|
Debiopharm
|
|
|
February 10, 2010
|
Therapeutic focus - Shots on goal could be the key for lung cancer
|
Novelos Therapeutics
|
|
|
February 04, 2010
|
Therapeutic focus - Huntexil at spout of dry Huntington's disease pipeline
|
NeuroSearch
|
|
|
January 18, 2010
|
Therapeutic focus - Behind Tracleer pulmonary fibrosis pipeline is a trickle
|
InterMune
|
|
|
January 05, 2010
|
Therapeutic focus - Novartis set to dominate eye care market
|
Novartis
|
|
|
December 22, 2009
|
Therapeutic focus - Gene therapy looking for a new hero
|
Ark Therapeutics
|
|
|
December 14, 2009
|
Therapeutic Focus – Cystic fibrosis market looking for breath of fresh air
|
Gilead Sciences
|
|
|
December 14, 2009
|
Ash 2009 EventAnalyzer – winners and losers
|
Sunesis Pharmaceuticals
|
|
|
November 30, 2009
|
Therapeutic focus – Drug developers fail to get the habit with opioid addiction
|
Alkermes
|
|
|
November 19, 2009
|
Therapeutic focus – Prevnar franchise's dominance of pneumococcal market set to continue
|
Pfizer
|
|
|
November 17, 2009
|
Therapeutic focus - Addex could be leading the mGluR pack
|
Addex Pharmaceuticals
|
|
|
November 10, 2009
|
Therapeutic focus - Lack of innovation in migraine market a headache
|
Merck & Co
|
|
|
October 21, 2009
|
Therapeutic focus - Promising therapies emerging for muscular dystrophy
|
GlaxoSmithKline
|
|
|
October 20, 2009
|
Therapeutic focus - Glaxo’s Votrient adds to the kinanse inhibitor success story
|
GlaxoSmithKline
|
|
|
October 08, 2009
|
Therapeutic focus - Novartis deal highlights novel late-stage antibiotic
|
Novartis
|
|
|
October 06, 2009
|
Therapeutic focus – Telomerase breakthrough not yet delivering the goods
|
Geron
|
|
|
September 11, 2009
|
Therapeutic focus - HDAC inhibitors gathering evidence of broader utility
|
4SC
|